Zafar_2019_Pak.J.Pharm.Sci_32_1155

Reference

Title : Synthesis and in vitro cholinesterase inhibitory potential of dihydropyridine derivatives - Zafar_2019_Pak.J.Pharm.Sci_32_1155
Author(s) : Zafar AM , Iqbal A , Ashraf M , Aslam S , Naureen S , Aslam N , Jabeen M , Sajid N , Ghafoor A , Noreen S , Shahi MN , Khan MA
Ref : Pak J Pharm Sci , 32 :1155 , 2019
Abstract :

Twelve derivatives of dihydropyridine derivatives (6-17) were synthesized and evaluated for in-vitro cholinesterases (AChE, BChE) inhibitory activity. All compounds showed potent activity with IC50 values between 0.21+/-0.003 to 147.14+/-0.12muM for AChE and among them five compounds showed potent activity with IC50 values 17.16+/-0.02 to 231.6+/-0.12muM for BChE when compared with standard Eserine (IC50 = 0.85+/-0.0001 muM (AChE) & 0.04+/-0.0001muM (BChE). The most potent compound 11 can be considered as potential lead compound showed an inhibition of 95.35+/-0.11 and IC50= 0.21+/-0.003 while compound 7 showed an inhibition of 83.45+/-0.13 and IC50= 17.16+/-0.02. It is concluded from structural activity relationship that the presence of nitro group at C-2 and C-4 position of dihydropyridine ring increase the acetyl cholinesterase and butyrylcholinesterase activities of these compounds while presence of -Br and -Cl also enhances the activities.

PubMedSearch : Zafar_2019_Pak.J.Pharm.Sci_32_1155
PubMedID: 31303584

Related information

Citations formats

Zafar AM, Iqbal A, Ashraf M, Aslam S, Naureen S, Aslam N, Jabeen M, Sajid N, Ghafoor A, Noreen S, Shahi MN, Khan MA (2019)
Synthesis and in vitro cholinesterase inhibitory potential of dihydropyridine derivatives
Pak J Pharm Sci 32 :1155

Zafar AM, Iqbal A, Ashraf M, Aslam S, Naureen S, Aslam N, Jabeen M, Sajid N, Ghafoor A, Noreen S, Shahi MN, Khan MA (2019)
Pak J Pharm Sci 32 :1155